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The evidence demonstrating the benefits of exercise is indisputable for healthy subjects,
and more recently, it is growing for Parkinson’s disease (PD) patients. Due to its easy
access, low cost, social facilitation and, above all, the symptomatic effect, clinical
exercise may have a profound impact on PD management. Especially considering that in
recent decades there have been no major advances from the pharmacological point
of view. Despite this, clinical exercise use it stills limited by the existent flaws in the
available evidence supporting its use and guiding its prescription as a PD therapeutic
intervention. We believe that a approach from the most relevant scientific and clinical
fields is crucial to establish the use of clinical exercise in PD patients’ routine care.
Therefore, in this viewpoint, we aim to highlight the importance of clinical exercise
as a therapeutic intervention in PD, and particularly of the benefits of applying sports
science principles to potentiate the use of clinical exercise as a therapeutic intervention
in PD management.
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Clinical exercise is a subtype of physical activity (PA), defined as the implementation of the sports
science knowledge involving physiologic, metabolic, and structural responses and prescribing
principles to short- and long-term PA with clinical relevance to the management of health
conditions (1–3).
Parkinson’s disease (PD) is currently the secondmost common neurodegenerative disease and it
is expected that its prevalence doubles over the next 20 years (4). Although several pharmacological
and surgical therapies proved to be effective for symptomatic control, there is no effective disease
modifying treatment yet, and the available symptomatic therapies have several flaws (5–7). Clinical
exercise has been recommended as a complement to pharmacological interventions for the
management of PD symptoms unresponsive to drug therapy, being presently also recognized as
one of the most promising therapeutic interventions with a disease-modifying effect (8–10).
Nonetheless, clinical exercise it still often not recognized as part of PD armamentarium with
only 47% complying with physical activity standard recommendations for adults (11).
With this viewpoint, we seek to highlight the importance of exercise as a therapeutic intervention
in PD and particularly of the benefits of applying sports science principles to potentiate the use of
exercise as a therapeutic intervention in PD management.
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TABLE 1 | Positive results of the different types of exercise.
Exercise type Benefits






- Quality of life
- Fall risk
Resistance training - Muscle strength
- Balance
- Functional mobility
- Quality of life
Balance training - Patients’ mobility
- Cadence and gait velocity
- Postural instability
CURRENT VIEWS ON THE BENEFITS OF
EXERCISE IN PD
Presently, there is a strong consensus that increasing the PA levels
of PD patients improves symptom management, physiological
and structural brain function (12).
Recent studies have also shown different benefits
associated with different types of exercise. In concrete:
endurance training has been associated with benefits on
tremor, bradykinesia, physical fitness, balance, gait speed,
motor function, quality of life, and falls risk (10, 13–
16); resistance training with benefits improving muscle
strength, balance, functional mobility, and quality of life;
and balance training seems to improve patients’ mobility and
postural instability (Table 1) (10, 12, 17, 18). In addition,
a 2017 case-control reported an improvement of motor
functions and whole-body metabolism in early/mid-stage PD
patients, after 3-months of combined endurance and strength
training (19).
Although structured exercise programs are the most
efficacious way to comply with the recommended levels of
PA, some preceding steps may be needed, because of the
sedentary lifestyle of most PD patients (6, 20). Some patients
may need to start by simply being more active throughout
the day, promoting different possible forms of PA, such as
parking away from the site and walking, doing housework,
climbing stairs, or gardening (20–22). As patients improve
their physical capacity, further benefits may be acquired with
structured exercise programs of moderate or high intensity
(21, 22).
According to recent published studies on exercise
interventions in PD, the heterogeneity of interventions tested,
the lack of standardize outcomes and the low quality of reporting
of the studies, affects the possibility of summarizing research
findings, limiting the possibility of establishing the most suitable
type, frequency, duration and intensity of clinical exercise for
each stage of PD (13, 23).
HOW CAN SPORT SCIENCE PRINCIPLES
POTENTIATE CLINICAL EXERCISE
INTERVENTIONS IN PD?
For a training session to be considered successful,
supercompensation should be achieved. This is the leading
concept of exercise training and is usually defined as an adaptive
response following a controlled application of stress on the body
and its subsequent regeneration (24).
To reach it, the major principles of exercise prescription, from
sports science field, should be followed. These are specificity,
overload, progression, variance, and reversibility (Figure 1)
(25, 26).
Specificity
The principle of specificity states that the effects of training
derived from an exercise program are particular to the muscular,
cardiorespiratory, and neurologic responses required by the
exercise performed, although they may indirectly affect the whole
body (22, 26). These should be the first to keep in mind when
designing an exercise program and requires to have clear the
predefined aim of the training (22, 26).
Most exercise interventions in PD address the major muscle
groups and are focused on a more global and functional
approach, however, a more focused and individualizes work of
some disease-related aspects, is also needed. Patients need to
perform functional exercises that improve gait, balance, transfers,
and physical capacity. Due to the physical deconditioning
associated with a sedentary lifestyle and age-related skeletal
muscle atrophy, a more focused work on some specific muscles
it’s also important (17, 27–29).
Overload and Progression
The overload and progression principles state that for an
intervention to induce improvement, or continue improving, a
tissue or organ functional capacity and/or efficiency, the stimulus
must be greater than the patient is normally accustomed to in
order to induce supercompensation (22, 26).
These two principles are operationalized through the principle
of prescription known as the FITT principle (frequency,
intensity, type, and time (duration) of training), which brings
exercise prescription closer to the management of other
therapeutic interventions, i.e., both should follow a detailed and
accurate rationale (30).
Due to the lack of standardization of the interventions and
low methodological quality of the studies, currently, it is not
yet possible to establish what is the most effective way of
operationalizing the FITT principle in PD (13, 21, 22). Although
with the necessary adjustments, the recommendation from The
Centers for Disease Control (CDC) and the American College of
Sports Medicine (ACSM), extensible to people with PD, could
be used (22, 31). According to these, patients should practice
endurance exercise of moderate-intensity for 30–60 min/day
on ≥5 days/week for a total of ≥150 min/week, or 20–60
min/day of vigorous-intensity endurance training ≥3 days/week
(≥75 min/week). Resistance and flexibility exercises should be
performed 2–3 days/week for each of the major joint and muscle
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FIGURE 1 | Major aspects of exercise prescription.
groups, and 2–3 days/week ofmulticomponent exercise involving
balance, agility, and coordination (22, 31).
Since the PD patients’ levels of PA are usually lower than
healthy controls, the stimulus needed to induce overload is
usually lower, being frequently reached with little changes in
the daily routine and/or through longer exercise sessions of low
intensity (20, 21).
Variance
The principle of variance requires that exercise programs include
a wide range of activities so that the body undergoes different
challenges and thereby maintains the individual’s interest in the
program (22).
The FIIT principle has shown to have little or very small
influence on patients’ adherence to exercise programs (31).
On the contrary, individualized, diversified exercise programs
according to individual preferences and enjoyment are critical
for adopting and adhering to an exercise program (32). Variance
could be achieved by performing different types of exercises in
different sessions or by combining one or more types in the
same session. It could also be reached alternating individualized
training with group sessions, or varying exercises, within the
same type of training (21, 31).
Evidence on exercise adherence in healthy adults, that may
be extrapolated to PD, suggests that: (1) the type of exercise
has no or very minimal impact on adherence; (2) adherence is
higher in moderate-intensity compared with vigorous-intensity
exercise; (3) exercise above the ventilatory threshold have a
negative impact on adherence; (4) supervised exercise enhances
adherence; (5) exercise environments with attractive distractions,
like television, or music, increase adherence; (6) structured
home-based programs improve exercise behavior; and (7)
strategies to enhance adherence to home- or community-based
interventions (e.g., pedometers, telecommunications, group
support) show to be effective (31).
Reversibility
Like any other pharmacological interventions, clinical exercised
has a limited duration of action. According to the principle
of reversibility, when the training stimulus stops, fitness levels
may return to baseline (22, 26). Therefore, PD patients need to
continue exercising to maintain the benefits (23).
According to a 2017 review on the long-term effects of exercise
in PD: (1) balance training is associated with the longest carry-
over effect (up to 12 months after completion of treatment)
when compared with the other types of training; (2) the majority
of progressive resistive and aerobic training programs produce
benefits that last for 12 weeks; and (3) the positive effects of
gait training on gait performance and walking capacity remain
up to 6 months after training completion (10). Evidence also
suggests that is needed a higher level of exercise to obtain
cardiorespiratory fitness and cardiometabolic health benefits
than to maintain those same benefits (31).
ARE EXERCISE PROGRAMS FOR PD
PATIENTS SAFE?
The individual response to physical stimuli can vary significantly
depending on intrinsic characteristics and health status,
especially in a heterogeneous population, such as PD (22).
Therefore any safe and effective exercise prescription needs
to take into account the application of training principles,
the individual’s functional capacity, health status, medication,
individual preferences, and goals (31, 33).
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The major problems associated with exercise practice are
musculoskeletal injuries and cardiovascular risks. To minimize
these risks, patients may benefit, especially beginner exercisers,
from an individualized evaluation of fitness levels, performed
by skilled personnel, with specific instruments, and validated
tests (24).
Two recent reviews on physiotherapy and exercise
interventions highlighted underreporting of the presence/
absence of adverse events (in both, more than half of the
included studies, did not report on adverse events) (23, 34). In
our opinion, this may be associated with different attitudes of
researchers, regarding safety issues, in non-pharmacological
trials compared with drug trials.
WHAT IS LACKING FOR TREATING PD
PATIENTS LIKE ATHLETES?
Being the most promising therapeutic intervention for delaying
disease progression with good results managing PD symptoms
that respond poorly to drug therapy, the confirmation of both
symptomatic, and disease-modifying effects of clinical exercise
could have a profound societal impact (6, 35). Indeed, one has to
bear in mind the good safety profile, easy access, low cost, and the
promotion of social interactions associated with clinical exercise
interventions (6, 35).
Despite this, the majority of patients are not engaged with
the exercise program. Evidence points to four main causes for
the underuse of exercise in PD symptom management: (1) the
absence of both a clear definition of exercise as a therapeutic
intervention and of standardized exercise programs; (2) a lack
of recommendations on the best trial design and recommended
outcomes to measure exercise efficacy; (3) a lack of knowledge
on how to prescribe and implement exercise programs in order
to optimize efficacy and adherence; and (4) a lack of awareness
and/or recognition by many health professionals and patients of
the therapeutic potential of clinical exercise (31, 36).
For patients to begin and maintain daily physical activity
and engage in a structured exercise program, they need it to be
recommended by health professionals. Since the majority of PD
patients are elderly, without exercise habits, it is important to
motivate them and ensure compliance, to discuss both the goals
and the rationale behind an exercise prescription (20, 22). For
those patients more sedentary and resistant to exercise, health
professionalsmay start promoting all possible forms of PA, before
recommending a structured exercise program (23, 37).
Exercise development programs have mainly been driven
by observational or investigator-initiated trials without clear
recommendations on the definition of exercise as a therapeutic
intervention, the best trial design, or the recommended outcomes
(31, 38). According to an analysis, conducted by our group, of all
clinical trials assessing exercise intervention in PD registered in
the WHO International Clinical Trials Registry Platform and the
ClinicalTrials.gov registries, from 2000 to 2017, almost 70% of
studies did not report their findings, and only 25.8% published
the results in scientific journals. From the published studies on
exercise in PD, 53% of the studies were evaluated as high or
uncertain risk of bias in at least half of the domains of the
Cochrane Risk of Bias assessment tool (23).
In our view, these limitations represent one of the bottlenecks
for further development of exercise in clinical populations. We
advocate that all science behind the design and undertaking of
pharmacological trials should be brought used to develop exercise
programs in order to guarantee the same rigor and precision as
required in the development of new medicines. We also believe
that the resolution of the underlying gaps in knowledge will
require a joint approach from the most relevant scientific and
clinical fields, such as movement disorders, sports science fields,
and experts in clinical trial methodology.
CONCLUSION
Exercise has been hailed as a new therapeutic intervention in
PD. However, as with any other therapeutic intervention, its
efficacy depends on the way it is prescribed and implemented.
To optimize exercise efficacy, a better understanding of the
principles of sports science and how to apply them in PD is
needed. In order to be consensually accepted as part of the PD
armamentarium, exercise development programs should follow
the same methodology of other new medicines. For that, we also
recommended multidisciplinary collaboration.
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